Analysis of CD20 and PD-L1 levels on small extracellular vesicles (sEV) produced by DLBCL cells and EBV-transformed B cells, and potential role in T cell inhibition

Authors: Hussein Akil, Hafidha Bentayeb, Marine Aitamer, Chantal Vignoles, Julie Abraham, Nathalie Gachard, Agnès Olivrie, Anne Guyot, Jessica Gobbo, Jean Feuillard, Hamasseh Shirvani, Danielle Troutaud

Source: Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-6 (2024)

Subject Terms: DLBCL, Human lymphoblastoid cell lines, sEV, Exosomes, CD20, PD-L1, Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2162-3619

Access URL: https://doaj.org/article/bb05245f007a4c53b3bd94a3e0158b2a

Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects

Authors: Hafidha Bentayeb, Marine Aitamer, Barbara Petit, Lydie Dubanet, Sabria Elderwish, Laurent Désaubry, Armand de Gramont, Eric Raymond, Agnès Olivrie, Julie Abraham, Marie-Odile Jauberteau, Danielle Troutaud

Source: Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-15 (2019)

Subject Terms: DLBCL, PHB, FL3, ERK signaling, Akt, Apoptosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s13046-019-1440-4; https://doaj.org/toc/1756-9966

Access URL: https://doaj.org/article/2f144c082943417e80c986adb6220bb5